• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human U7 snRNA-associated Sm-like protein LSm11 (LSM11)

ACP24578

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP24578 Target NameLSM11
Target SynonymsLSM11U7 snRNA-associated Sm-like protein LSm11FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-360
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP83369
Background Information
  • Uniprot Id

    P83369

  • Target Species

    Human

  • Target Name

    LSM11

  • Target Full Name

    U7 snRNA-associated Sm-like protein LSm11

  • Target Function

    Component of the U7 snRNP complex that is involved in the histone 3'-end pre-mRNA processing. Increases U7 snRNA levels but not histone 3'-end pre-mRNA processing activity, when overexpressed. Required for cell cycle progression from G1 to S phases. Binds specifically to the Sm-binding site of U7 snRNA.

  • Target Subcellular Location

    Nucleus.

  • Target Protein Families

    SnRNP Sm proteins family

  • Target Synonyms

    LSM11U7 snRNA-associated Sm-like protein LSm11

  • Target Background

    Enables U7 snRNA binding activity. Involved in positive regulation of G1/S transition of mitotic cell cycle. Located in nuclear body. Part of U7 snRNP and telomerase holoenzyme complex. Implicated in Aicardi-Goutieres syndrome.

Inquire Recombinant Human U7 snRNA-associated Sm-like protein LSm11 (LSM11) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification